These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1767793)

  • 1. Effects of hachimijiogan on dopamine, serotonin and vasoactive intestinal peptide in plasma and hypothalamus in sulpiride-induced hyperprolactinemic rats.
    Usuki S; Ichikawa Y
    Am J Chin Med; 1991; 19(3-4):217-22. PubMed ID: 1767793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin gene expression and secretion during pregnancy and lactation in the rat: role of dopamine and vasoactive intestinal peptide.
    Escalada J; Cacicedo L; Ortego J; Melian E; Sánchez-Franco F
    Endocrinology; 1996 Feb; 137(2):631-7. PubMed ID: 8593812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible role of vasoactive intestinal peptide in the hyperprolactinemia induced by ethanol.
    Seilicovich A; Duvilanski B; Debeljuk L; Lasaga M; Pisera D; Afione S; Traktenberg R; Diaz MC
    Regul Pept; 1991 Mar; 33(1):39-44. PubMed ID: 2047543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperprolactinemia reduces vasoactive intestinal peptide in the anterior pituitary glands of rats.
    Prysor-Jones RA; Silverlight JJ; Jenkins JS
    Neurosci Lett; 1987 Oct; 80(3):333-8. PubMed ID: 3683988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between hypothalamic dopaminergic and opioidergic systems in the photoperiodic regulation of pulsatile luteinizing hormone secretion in sheep.
    Tortonese DJ
    Endocrinology; 1999 Feb; 140(2):750-7. PubMed ID: 9927302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulpiride in combination with fluvoxamine increases in vivo dopamine release selectively in rat prefrontal cortex.
    Ago Y; Nakamura S; Baba A; Matsuda T
    Neuropsychopharmacology; 2005 Jan; 30(1):43-51. PubMed ID: 15383832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hachimijiogan treatment is effective in the management of infertile women with hyperprolactinemia or bromocriptine-resistant hyperprolactinemia.
    Usuki S; Usuki Y
    Am J Chin Med; 1989; 17(3-4):225-41. PubMed ID: 2633624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation by serotonin of vasoactive intestinal polypeptide release into rat hypophysial portal blood.
    Shimatsu A; Kato Y; Matsushita N; Katakami H; Yanaihara N; Imura H
    Endocrinology; 1982 Jul; 111(1):338-40. PubMed ID: 7084118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implication of pituitary vasoactive intestinal peptide in dopaminergic inhibition of estrogen-induced pituitary hyperplasia and vascular endothelial growth factor expression.
    Gómez O; Balsa JA
    Neuroendocrinology; 2004; 80(5):324-31. PubMed ID: 15677882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoparacrine action of vasoactive intestinal peptide on dopaminergic control of prolactin secretion.
    Balsa JA; Sánchez-Franco F; Lorenzo MJ; Pazos F; Lara JI; Cacicedo L
    Endocrinology; 1996 Feb; 137(2):508-13. PubMed ID: 8593796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of vasoactive intestinal peptide and serotonin in the paraventricular nucleus reflects the periodicity of the endogenous stimulatory rhythm regulating prolactin secretion.
    Arey BJ; Freeman ME
    Endocrinology; 1992 Aug; 131(2):736-42. PubMed ID: 1639019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of prostaglandin E1 on vasoactive intestinal polypeptide release from the hypothalamus and on prolactin secretion from the pituitary in rats.
    Shimatsu A; Kato Y; Matsushita N; Katakami H; Ohta H; Yanaihara N; Imura H
    Endocrinology; 1983 Dec; 113(6):2059-64. PubMed ID: 6685619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of passive immunization with antisera to vasoactive intestinal polypeptide and peptide histidine isoleucine amide on 5-hydroxy-L-tryptophan-induced prolactin release in rats.
    Kaji H; Chihara K; Abe H; Kita T; Kashio Y; Okimura Y; Fujita T
    Endocrinology; 1985 Nov; 117(5):1914-9. PubMed ID: 3876209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of selective D1- or D2-like dopamine receptor antagonists with acute "binge" pattern cocaine on corticotropin-releasing hormone and proopiomelanocortin mRNA levels in the hypothalamus.
    Zhou Y; Spangler R; Yuferov VP; Schlussmann SD; Ho A; Kreek MJ
    Brain Res Mol Brain Res; 2004 Nov; 130(1-2):61-7. PubMed ID: 15519677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of sulpiride on the hypothalamic monoaminergic regulation of prolactin formation and milk secretion].
    Aliev MG; Kocharli RKh
    Fiziol Zh SSSR Im I M Sechenova; 1983 Jun; 69(6):756-60. PubMed ID: 6873386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyrotrophin-releasing hormone, vasoactive intestinal peptide, prolactin-releasing peptide and dopamine regulation of prolactin secretion by different lactotroph morphological subtypes in the rat.
    Christian HC; Chapman LP; Morris JF
    J Neuroendocrinol; 2007 Aug; 19(8):605-13. PubMed ID: 17620102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. R(+)-8-OH-DPAT, a serotonin(1A) receptor agonist, potentiated S(-)-sulpiride-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatum.
    Ichikawa J; Meltzer HY
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1227-32. PubMed ID: 10565846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothalamic factors involved in the endogenous stimulatory rhythm regulating prolactin secretion.
    Arey BJ; Freeman ME
    Endocrinology; 1989 Feb; 124(2):878-83. PubMed ID: 2521468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of hypothalamic hyperprolactinemia.
    Ferrari C; Rampini P; Benco R; Caldara R; Scarduelli C; Crosignani PG
    J Clin Endocrinol Metab; 1982 Nov; 55(5):897-901. PubMed ID: 6811605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential increase in pituitary prolactin versus vasoactive intestinal peptide as a function of estradiol benzoate dose in the ovariectomized rat.
    Carrillo AJ; Doherty PC; Guan XB; Sturtevant JR; Walro DG
    Endocrinology; 1991 Jan; 128(1):131-8. PubMed ID: 1986914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.